NasdaqGM - Delayed Quote • USD
HCW Biologics Inc. (HCWB)
At close: April 25 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.57 | -0.55 |
| Low Estimate | 0 | 0 | -0.57 | -0.55 |
| High Estimate | 0 | 0 | -0.57 | -0.55 |
| Year Ago EPS | -0.14 | -0.12 | -0.7 | -0.57 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | 2.84M | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.14 | -0.15 | -0.13 | -0.14 |
| EPS Actual | -0.14 | -0.12 | -0.14 | -0.3 |
| Difference | 0 | 0.03 | -0.01 | -0.16 |
| Surprise % | 0.00% | 20.00% | -7.70% | -114.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.57 | -0.55 |
| 7 Days Ago | 0 | 0 | -0.57 | -0.55 |
| 30 Days Ago | 0 | 0 | -0.57 | -0.59 |
| 60 Days Ago | 0 | 0 | -0.57 | -0.59 |
| 90 Days Ago | 0 | 0 | -0.57 | -0.59 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HCWB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 2.60% |
| Next Qtr. | -- | -- | -- | 13.40% |
| Current Year | 18.60% | -- | -- | 5.20% |
| Next Year | 3.50% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.11% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | EF Hutton: Buy | 4/19/2023 |
| Reiterates | EF Hutton: Buy | 3/30/2023 |
| Reiterates | EF Hutton: Buy | 3/23/2023 |
| Initiated | JonesTrading: Buy | 11/8/2022 |
| Initiated | Maxim Group: Buy | 3/24/2022 |
| Initiated | EF Hutton: Buy | 11/19/2021 |
Related Tickers
TCBPW TC Biopharm (Holdings) Plc
0.0208
+3.48%
ZA8.BE Zymeworks Inc
7.55
-0.66%
KTTAW Pasithea Therapeutics Corp.
0.0140
+12.00%
SRZNW Surrozen, Inc.
0.0323
+46.15%
SBMFF Sino Biopharmaceutical Limited
0.3150
0.00%
EFTRW eFFECTOR Therapeutics, Inc.
0.0385
+54.62%
NTRBW Nutriband Inc.
0.9500
0.00%
VXLLF Vaxil Bio Ltd.
0.0050
-5.66%
RNXT RenovoRx, Inc.
1.2100
-1.63%
OCEAW Ocean Biomedical, Inc.
0.1124
+2.18%